Abstract
Background The COVID-19 pandemic has exacerbated the obesity epidemic, with both adults and children demonstrating rapid weight gain during the pandemic. However, the impact of having a COVID-19 diagnosis on this trend is not known.
Methods Using longitudinal data from January 2019 to June 2023 collected by the US National Institute for Health’s National COVID Cohort Collaborative (N3C), children (age 2–18 years) with positive COVID-19 test results (n=11,474, 53% male, mean [SD] age 5.57 [±3.29] years, 54% white, mean [SD] 5.2 [±2.9] BMI observations per participants) were matched with COVID-19 negative children with identical demographic characteristics and similar observation window. We compared BMI percentile trajectories between the COVID-19 positive and COVID-19 negative cohorts, with further evaluation performed on COVID-19 positive patients stratified by hospitalization status.
Results COVID-19 positive patients had a greater increase in %BMIp95 than COVID-19 negative patients (average increase of 2.34 (±7.73) compared to 1.46 (±6.09), p<0.0005). COVID-19 positive patients gained more weight after their diagnosis of COVID-19 than before. Non-hospitalized children gained more weight than hospitalized children (average increase in %BMIp95 of 2.38 (±7.65)) compared to 1.87 (±8.54)). Mixed effect regression analyses demonstrated that these associations remained even after adjusting for time, demographics, and baseline %BMIp95.
Conclusions Having a COVID-19 diagnosis was associated with more rapid weight gain, especially after diagnosis and early in the pandemic. Future research should explore the reasons for this association and the implications for future health emergencies.
Authors’ Contributions M.M.M. drafted the initial manuscript and assisted with the data curation, formal analysis, methodology, and visualization. T.T.P. assisted with the study design, interpretation of results, funding acquisition, and manuscript drafting and editing. C.T.B. and C.G.C assisted with formal analysis and interpretation of results. L.A.P. assisted with the interpretation of results and manuscript editing. R.B. supervised the study with study design, resources, funding acquisition, and manuscript editing. All authors assisted in the conceptualization of the study and approved it for publication.
Author Disclosure Statement The authors declare no conflicts of interest.
Impact Statement This study investigating the weight trajectories of children during the COVID-19 pandemic shows that the pandemic has led to a significant increase in weight gain among US children aged 6-11, with boys gaining more weight than girls. Non-hospitalized COVID-19-positive children were found to be at greater risk of gaining weight.
Declarations The analyses described in this publication were conducted with data or tools accessed through the NCATS N3C Data Enclave https://covid.cd2h.org and N3C Attribution & Publication Policy v 1.2-2020-08-25b supported by NCATS U24 TR002306, Axle Informatics Subcontract: NCATS-P00438-B, [DUR RP-0BDD0E] and was supported by NIH awards, P20GM103446 and U54-GM104941. This research was possible because of the patients whose information is included within the data and the organizations (https://ncats.nih.gov/n3c/resources/data-contribution/data-transfer-agreement-signatories) and scientists who have contributed to the ongoing development of this community resource [https://doi.org/10.1093/jamia/ocaa196]
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by NIH awards, P20GM103446 and U54-GM104941
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of University of Delaware gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
mmmdip{at}udel.edu
thaoly.phan{at}nemours.org
bramante{at}umn.edu
chute{at}jhu.edu
lee.pyles{at}hsc.wvu.edu
rbi{at}udel.edu
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.